UCHL-3 as a potential biomarker of ovarian cancer

CONCLUSION: UCHL3 overexpression contributes to aggressive progression, poor survival, and chemoresistance in OC. Therefore, UCHL3 may be a candidate prognostic biomarker and potential target for controlling progression and platinum resistance in OC.PMID:38266402 | DOI:10.1016/j.ygyno.2023.12.031
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Source Type: research